infectious-disease

Documents about infectious-disease

• MOLECULAR BIOSENSOR PLATFORMS FOR RNA MULTI-TYPING#254785ScholarBank@NUS
• Strategies to support implementation of infectious disease decision support systems: a scoping review.#340615NCBI PubMed Central
• Risks, Contracts and Infectious Disease in the UK NHS Managed Market, 1997-1999#644820LSHTM Data Compass
• Effectiveness of Chlorhexidine Bathing in the Neonatal Intensive Care Unit#860202ClinicalTrials.gov
• Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19)#911891ClinicalTrials.gov
• SENSORY NEURONS MEDIATE HOST RESISTANCE TO SKIN-PENETRATING HELMINTH INFECTIONS#929163ScholarlyCommons
• Epidemic "momentum" and a conservation law for infectious disease dynamics#984920arXiv (All)
• Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay#1031649ClinicalTrials.gov
• Cross-Country Learning for National Infectious Disease Forecasting Using European Data#1034698arXiv (All)
• 21 U.S.C. § 360n-1 — Priority review for qualified infectious disease products#577416US Code (LII)
• Beyond silos: Drivers and barriers to intersectoral collaboration in zoonotic disease surveillance and response in the Greater Accra Metropolitan Area, Ghana#25946PLOS
• Theiler's murine encephalomyelitis virus as the infectious agent for a virally induced mouse model of Parkinson's disease#123209Europe PMC
• Mapping the last mile: Micro-stratification for sustained visceral leishmaniasis elimination in Bangladesh#172217PLOS
• Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?#909978ClinicalTrials.gov
• Evaluating the Transition From Pediatric to Adult Care Among Adolescents With Chronic Granulomatous Disease#994902ClinicalTrials.gov
• Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older#67689ClinicalTrials.gov
• Epidemiology of surgical occupational exposures in an infectious disease hospital: a 5-year retrospective study.#227937NCBI PubMed Central
• Code and data for: Composable probabilistic models can lower barriers to rigorous infectious disease modelling#231915LSHTM Data Compass
• Identification of required competencies for specialist nurses in infectious disease care: A modified Delphi study.#285092NCBI PubMed Central
• Conflict-Driven Displacement and the Risk of Infectious Disease Outbreaks in the Middle East.#297531NCBI PubMed Central
• Sivextro in Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global Observational Study#307471ClinicalTrials.gov
• A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine#321553ClinicalTrials.gov
• Estimating Infectious Disease Importation Risk during the 2026 FIFA World Cup#339585bioRxiv / medRxiv
• Modelling mass asymptomatic testing strategies for early containment of infectious disease outbreaks in prisons#414807Europe PMC
• Attitudes toward free speech, content moderation, and punishment of misinformation spreaders during infectious disease outbreaks.#436876NCBI PubMed Central
• UNiD 3D VBR Register#831716ClinicalTrials.gov
• Steroid Withdrawal in Pediatric Kidney Transplant Recipients#851548ClinicalTrials.gov
• Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19#904690ClinicalTrials.gov
• University of Utah COVID-19 Hydrochloroquine Trial#911608ClinicalTrials.gov
• Kalman Filtering and Smoothing for Improving Precision in Horvitz--Thompson Estimation of Infectious Disease Prevalence#987086arXiv (All)
• EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial#1009599ClinicalTrials.gov
• 21 U.S.C. § 355f — Extension of exclusivity period for new qualified infectious disease products#577369US Code (LII)
• Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis#6764OpenAlex
• Using Probabilistic Cellular Automata to Model the Transmission of an Emerging Infectious Disease of Amphibians-A Preliminary Model#676123Europe PMC
• VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Subjects With Underlying Disease at High-risk for Worsening COVID-19#858534ClinicalTrials.gov
• Monoclonal Antibody Treatment of Crohn's Disease#1047293ClinicalTrials.gov
• Impact of Infectious Diseases Consultation on Vaccination Coverage Among People Waiting for a Kidney Transplant at the Clermont-Ferrand Hospital#1031166ClinicalTrials.gov
• Analyzing the collaborative development needs of grassroots centers for disease control and prevention using the Kano model: A case study of China’s Chengdu–Chongqing Economic Circle#120222PLOS
• Hybrid multi-disease SEIR and transformer models for infectious disease forecasting in Zambia#331732Springer Nature OA
• Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up#904108ClinicalTrials.gov
• Spatial representativeness matters for Climate-Driven Dengue Forecasting#136447PLOS
• Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients#162499ClinicalTrials.gov
• Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years#162528ClinicalTrials.gov
• Prevalence and Associated Mortality of Infections by Multidrug-Resistant Organisms in Adults Intensive Care Units#174924ClinicalTrials.gov
• When is elimination of an infectious disease cost- effective? An analytical framework to guide elimination priorities#248600Spiral
• WHO foodborne disease estimates 2000-21: bridging the burdens of infectious and non-communicable diseases.#289170PubMed
• Vaccination Education Through Pharmacists and Senior Centers (VEPSC)#307309ClinicalTrials.gov
• Diseases Have No Eyes#426908DOAB PROD Instance
• Resilience as recovery: stakeholder perspectives on Uganda's health system response to infectious disease shocks.#434184NCBI PubMed Central
• The impact of ambiguously reported epidemiological parameters for infectious disease modelling and recommended best practices#447001Spiral